This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novartis Ag. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Rhys Salter: Innovator in Pharmaceutical Chemistry
Introduction
Rhys Salter is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on spirocyclic lactams.
Latest Patents
Rhys Salter holds a patent for "Certain substituted spirocyclic lactams and use thereof as pharmaceuticals." This invention relates to novel 2-(6-oxo-1,7-diaza-spiro[4.4]non-7-yl)-propionamides, which are defined by specific chemical structures. The patent outlines their preparation, use as pharmaceuticals, and the pharmaceutical compositions that contain them. He has 1 patent to his name.
Career Highlights
Salter is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on developing innovative pharmaceutical solutions that address various medical needs.
Collaborations
Throughout his career, Rhys has collaborated with esteemed colleagues such as Yves Auberson and Ralf Glatthar. These collaborations have further enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Rhys Salter's contributions to pharmaceutical chemistry, particularly through his patented innovations, highlight his role as a key figure in the industry. His work continues to influence the development of new therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile